Development of a Life Skills Intervention for Young Adolescents Perinatally-Infected With HIV and Their Caregivers

NCT00224900 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 10

Last updated 2017-02-28

No results posted yet for this study

Summary

During this phase of the study, a focus group will be conducted with young adolescents perinatally infected with HIV and with their caregivers to develop and evaluate the content of the proposed intervention. The purpose of the focus groups is to identify key issues and challenges that often face young adolescents perinatally infected with HIV and their caregivers as well as to elicit suggestions to enhance the feasibility and acceptability of the proposed intervention. The focus groups will be audio recorded and transcribed and reviewed by all involved in future protocol development. Themes will be pulled directly from the focus groups to guide examples and areas of emphasis in the intervention. In addition, proposed measures will be administered to the adolescents and their caregivers and assessed for appropriateness for this population.

Conditions

  • HIV Infection

Sponsors & Collaborators

  • National Institute on Drug Abuse (NIDA)

    collaborator NIH
  • National Institute of Mental Health (NIMH)

    collaborator NIH
  • National Institute on Alcohol Abuse and Alcoholism (NIAAA)

    collaborator NIH
  • University of North Carolina, Chapel Hill

    lead OTHER

Principal Investigators

  • Ahna L Hoff, Ph.D. · Case Western Reserve University School of Medicine and Rainbow Babies and Childrens Hospital

Eligibility

Min Age
11 Years
Max Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-09-30
Primary Completion
2006-05-31
Completion
2006-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00224900 on ClinicalTrials.gov